Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05102877 · ClinicalTrials.gov registry record · NA
Sensory Versus Motor Level Neuromuscular Electrical Stimulation
A NA study, sponsored by Casa Colina Hospital and Centers for Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05102877: Completed NA study, sponsored by Casa Colina Hospital and Centers for Healthcare.
NCT05102877 is a NA study that has completed, run by Casa Colina Hospital and Centers for Healthcare. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05102877, a NA study, has completed, sponsored by Casa Colina Hospital and Centers for Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Dysphagia is a serious cause of morbidity and mortality in stroke survivors. Electrical stimulation is often included as part of the treatment plan for dysphagia, and can be applied at a sensory or motor level intensity. However, evidence to support these different modes of stimulation is lacking. This study compared the effectiveness of sensory and motor level stimulation on post-stroke dysphagia.
Primary Outcome
7 point swallow scale the Functional oral intake scale (FOIS) lowest score = 1; highest = 7.
Interventions
- DEVICE Neuromuscular electrical stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-09-19 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
What the finished NCT05102877 record still lists
NCT05102877 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Neuromuscular electrical stimulation is the first listed.
NCT05102877 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05102877 about?
NCT05102877 is a clinical study titled "Sensory Versus Motor Level Neuromuscular Electrical Stimulation". Dysphagia is a serious cause of morbidity and mortality in stroke survivors. Electrical stimulation is often included as part of the treatment plan for dysphagia, and can be applied at a sensory or motor level intensity. However, evidence to support these different modes of stimulation is lacking. T...
What is the current status of trial NCT05102877?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2018-09-19. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT05102877?
The interventions under investigation include: Neuromuscular electrical stimulation (DEVICE).
Who is sponsoring clinical trial NCT05102877?
This trial is sponsored by Casa Colina Hospital and Centers for Healthcare, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05102877's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI